AmBisome liposomāls amfotericīns B 50 mg pulveris infūziju šķīduma pagatavošanai Lotyšsko - lotyština - Zāļu valsts aģentūra

ambisome liposomāls amfotericīns b 50 mg pulveris infūziju šķīduma pagatavošanai

gilead sciences ireland uc, ireland - amfotericīns b - pulveris infūziju šķīduma pagatavošanai - 50 mg

Dasatinib Accord Evropská unie - lotyština - EMA (European Medicines Agency)

dasatinib accord

accord healthcare s.l.u. - dasatinib - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - antineoplastiski līdzekļi - dasatinib accord is indicated for the treatment of adult patients with:• ph+ acute lymphoblastic leukaemia (all) with resistance or intolerance to prior therapy. dasatinib accord is indicated for the treatment of paediatric patients with:• newly diagnosed ph+ all in combination with chemotherapy.

Dasatinib Accordpharma Evropská unie - lotyština - EMA (European Medicines Agency)

dasatinib accordpharma

accord healthcare s.l.u. - dasatinib - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - antineoplastiski līdzekļi - dasatinib accordpharma is indicated for the treatment of adult patients with: newly diagnosed philadelphia chromosome positive (ph+) chronic myelogenous leukaemia (cml) in the chronic phase.  chronic, accelerated or blast phase cml with resistance or intolerance to prior therapy including imatinib.  ph+ acute lymphoblastic leukaemia (all) and lymphoid blast cml with resistance or intolerance to prior therapy. dasatinib accordpharma is indicated for the treatment of paediatric patients with: newly diagnosed ph+ cml in chronic phase (ph+ cml-cp) or ph+ cml-cp resistant or intolerant to prior therapy including imatinib.  newly diagnosed ph+ all in combination with chemotherapy.

Rasagiline Mylan Evropská unie - lotyština - EMA (European Medicines Agency)

rasagiline mylan

mylan pharmaceuticals limited - rasagilīna tartrāts - parkinsona slimība - anti-parkinsona zāles - rasagiline mylan norāda idiopātiska parkinsona slimība (pd) ārstēšanai monoterapijā (bez levodopa) vai kā papildinājumu terapiju pacientiem ar beigām deva svārstības (ar levodopa).

Rasagiline ratiopharm Evropská unie - lotyština - EMA (European Medicines Agency)

rasagiline ratiopharm

teva b.v. - rasagiline - parkinsona slimība - anti-parkinsona zāles - rasagiline ratiopharm norāda idiopātiska parkinsona slimība (pd) ārstēšanai monoterapijā (bez levodopa) vai kā papildinājumu terapiju pacientiem ar beigām deva svārstības (ar levodopa).

Rasagiline Accord 1 mg tabletes Lotyšsko - lotyština - Zāļu valsts aģentūra

rasagiline accord 1 mg tabletes

accord healthcare b.v., netherlands - rasagilīns - tablete - 1 mg